YanAn Bicon Pharmaceutical Listed Company
Symboli: 002411.SZ
SHZ
0.62
CNYMarkkinahinta tänään
-0.5881
P/E-suhde
-0.0152
PEG-suhde
950.01M
MRK Cap
- 0.00%
DIV Tuotto
YanAn Bicon Pharmaceutical Listed Company (002411-SZ) Tilinpäätöstiedotteet
Tase
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 3267.61 | 950.2 | 842.6 | 710.4 | |||||||||||||||||
balance-sheet.row.short-term-investments | 194.74 | 73.1 | -240.1 | -216.7 | |||||||||||||||||
balance-sheet.row.net-receivables | 19813.77 | 4260.2 | 5748.3 | 5945.8 | |||||||||||||||||
balance-sheet.row.inventory | 3740.51 | 788.2 | 978.6 | 763.9 | |||||||||||||||||
balance-sheet.row.other-current-assets | 319.4 | 76.3 | 106.9 | 85.1 | |||||||||||||||||
balance-sheet.row.total-current-assets | 27141.29 | 6074.9 | 7676.5 | 7505.3 | |||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 18876.13 | 2910 | 6651.1 | 8593.4 | |||||||||||||||||
balance-sheet.row.goodwill | 6512.07 | 1614.7 | 1641.3 | 1641.3 | |||||||||||||||||
balance-sheet.row.intangible-assets | 2412.53 | 531 | 670.9 | 774.6 | |||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 8924.59 | 2145.8 | 2312.2 | 2416 | |||||||||||||||||
balance-sheet.row.long-term-investments | -30.09 | -15 | 288.5 | 261.6 | |||||||||||||||||
balance-sheet.row.tax-assets | 2272.59 | 984.9 | 151.9 | 171.9 | |||||||||||||||||
balance-sheet.row.other-non-current-assets | 9353.57 | 2761.1 | 1643.1 | 259.3 | |||||||||||||||||
balance-sheet.row.total-non-current-assets | 39396.78 | 8786.7 | 11046.8 | 11702.2 | |||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-assets | 66538.08 | 14861.6 | 18723.3 | 19207.4 | |||||||||||||||||
balance-sheet.row.account-payables | 7878.36 | 1892 | 2036.3 | 2142.7 | |||||||||||||||||
balance-sheet.row.short-term-debt | 10572.87 | 1553 | 4617.7 | 4005.3 | |||||||||||||||||
balance-sheet.row.tax-payables | 3673.99 | 1062.4 | 1031.9 | 779 | |||||||||||||||||
balance-sheet.row.long-term-debt-total | 2554.55 | 231.9 | 283.2 | 1084.8 | |||||||||||||||||
Deferred Revenue Non Current | 504.79 | 126.1 | 132.9 | 139.2 | |||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 58 | - | - | - | |||||||||||||||||
balance-sheet.row.other-current-liab | 14694.58 | 4597 | 20.2 | 46.3 | |||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 4284.47 | 656.7 | 727.6 | 1285.9 | |||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.capital-lease-obligations | 55.85 | 12.6 | 29.9 | 19.3 | |||||||||||||||||
balance-sheet.row.total-liab | 37430.28 | 8698.7 | 10650.4 | 10276.4 | |||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.common-stock | 7113.22 | 1778.3 | 1778.3 | 1778.3 | |||||||||||||||||
balance-sheet.row.retained-earnings | -1660.9 | -1317.7 | 247.4 | 1204.5 | |||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 21853.18 | 5312.8 | 5601.3 | 5522.6 | |||||||||||||||||
balance-sheet.row.total-stockholders-equity | 27305.5 | 5773.3 | 7627 | 8505.5 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 66538.08 | 14861.6 | 18723.3 | 19207.4 | |||||||||||||||||
balance-sheet.row.minority-interest | 1802.3 | 389.5 | 446 | 425.6 | |||||||||||||||||
balance-sheet.row.total-equity | 29107.8 | 6162.9 | 8073 | 8931 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 66538.08 | - | - | - | |||||||||||||||||
Total Investments | 213.13 | 58.1 | 48.4 | 44.9 | |||||||||||||||||
balance-sheet.row.total-debt | 13127.42 | 1784.9 | 4900.9 | 5090.1 | |||||||||||||||||
balance-sheet.row.net-debt | 10006.06 | 907.8 | 4058.2 | 4379.7 |
Kassavirtalaskelma
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -1560.63 | -1054.7 | -659.7 | -1054.3 | |||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 350.1 | 403.3 | 338.9 | |||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | 2112.3 | -732.8 | -1104.2 | |||||||||||||||||
cash-flows.row.account-receivables | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.inventory | 0 | -8.4 | -212.8 | -1.6 | |||||||||||||||||
cash-flows.row.account-payables | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.other-working-capital | 0 | 2120.8 | -520 | -1102.6 | |||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 1517.5 | 1590.6 | 1454.5 | |||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -1560.63 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -1498.5 | -1452.8 | -281.1 | -143.7 | |||||||||||||||||
cash-flows.row.acquisitions-net | 1335.58 | 1335.6 | 0 | 0.1 | |||||||||||||||||
cash-flows.row.purchases-of-investments | -25.7 | -25.6 | 205.5 | -0.3 | |||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0.01 | 996 | 3.8 | 0.7 | |||||||||||||||||
cash-flows.row.other-investing-activites | 985.62 | -10.3 | 132.8 | 1194.8 | |||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 797.01 | 842.8 | 60.9 | 1051.7 | |||||||||||||||||
cash-flows.row.debt-repayment | -3769.74 | -3339 | -647.6 | -3023.1 | |||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.dividends-paid | -2054.05 | -2021.4 | -200.1 | -431.2 | |||||||||||||||||
cash-flows.row.other-financing-activites | 2695.35 | 2222.5 | 460.1 | 2738.8 | |||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -3128.44 | -3137.9 | -387.6 | -715.5 | |||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 23.75 | 23.7 | -1 | -0.4 | |||||||||||||||||
cash-flows.row.net-change-in-cash | -227.08 | 653.9 | 273.8 | -29.3 | |||||||||||||||||
cash-flows.row.cash-at-end-of-period | 2538.32 | 1154.2 | 500.7 | 226.8 | |||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 2765.4 | 500.3 | 226.8 | 256.1 | |||||||||||||||||
cash-flows.row.operating-cash-flow | -1560.63 | 2925.3 | 601.4 | -365 | |||||||||||||||||
cash-flows.row.capital-expenditure | -1498.5 | -1452.8 | -281.1 | -143.7 | |||||||||||||||||
cash-flows.row.free-cash-flow | -3059.13 | 1472.4 | 320.3 | -508.8 |
Tuloslaskelmarivi
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 7057.74 | 8106.3 | 7663.2 | 6939.5 | |||||||||||||||||
income-statement-row.row.cost-of-revenue | 5817.12 | 6075.1 | 5311.9 | 5613.1 | |||||||||||||||||
income-statement-row.row.gross-profit | 1240.61 | 2031.2 | 2351.2 | 1326.4 | |||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||
income-statement-row.row.research-development | 127.63 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-general-administrative | 34.99 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 290.11 | - | - | - | |||||||||||||||||
income-statement-row.row.other-expenses | 1153.16 | 1157.5 | 325.1 | 306.9 | |||||||||||||||||
income-statement-row.row.operating-expenses | 1605.89 | 1719.5 | 856.8 | 946.7 | |||||||||||||||||
income-statement-row.row.cost-and-expenses | 7423.02 | 7794.6 | 6168.7 | 6559.8 | |||||||||||||||||
income-statement-row.row.interest-income | -4.19 | -6 | 16 | 20.7 | |||||||||||||||||
income-statement-row.row.interest-expense | 201.51 | 283.7 | 357.9 | 1135.6 | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 290.11 | - | - | - | |||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -518.6 | -2001.5 | -1587.9 | -2048.9 | |||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-operating-expenses | 1153.16 | 1157.5 | 325.1 | 306.9 | |||||||||||||||||
income-statement-row.row.total-operating-expenses | -518.6 | -2001.5 | -1587.9 | -2048.9 | |||||||||||||||||
income-statement-row.row.interest-expense | 201.51 | 283.7 | 357.9 | 1135.6 | |||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 1448.87 | 350.1 | 403.3 | 338.9 | |||||||||||||||||
income-statement-row.row.ebitda-caps | -271.28 | - | - | - | |||||||||||||||||
income-statement-row.row.operating-income | -1720.15 | 342.9 | 1219.9 | 930.6 | |||||||||||||||||
income-statement-row.row.income-before-tax | -2238.75 | -1658.6 | -368 | -1118.3 | |||||||||||||||||
income-statement-row.row.income-tax-expense | -692.52 | -603.9 | 291.7 | -45.5 | |||||||||||||||||
income-statement-row.row.net-income | -1560.63 | -1054.7 | -659.7 | -1072.8 |
Usein kysytty kysymys
Mikä on YanAn Bicon Pharmaceutical Listed Company (002411.SZ) taseen loppusumma?
YanAn Bicon Pharmaceutical Listed Company (002411.SZ) kokonaisvarat ovat 14861598713.000.
Mikä on yrityksen vuotuinen liikevaihto?
Vuotuinen liikevaihto on 3146759640.000.
Mikä on yrityksen voittomarginaali?
Yrityksen voittomarginaali on 0.155.
Mikä on yrityksen vapaa kassavirta?
Vapaa kassavirta on -1.981.
Mikä on yrityksen nettovoittomarginaali?
Nettovoittomarginaali on -0.303.
Mikä on yrityksen kokonaistulot?
Kokonaisliikevaihto on -0.342.
Mikä on YanAn Bicon Pharmaceutical Listed Company (002411.SZ) nettovoitto (nettotulos)?
Nettovoitto (nettotulos) on -1054699022.740.
Mikä on yrityksen kokonaisvelka?
Kokonaisvelka on 1784935683.000.
Mikä on yrityksen toimintakulujen määrä?
Toimintakulut ovat 1719493052.000.
Mikä on yrityksen kassan määrä?
Yrityksen kassavarat ovat 489995625.000.